US-backed hepatitis B vaccine trial in Guinea-Bissau halted after backlash

A CDC-funded hepatitis B vaccine trial in newborns in Guinea-Bissau has been halted after the lead researcher confirmed it will not proceed due to lack of governmental approval. The trial had drawn global backlash over ethical concerns. This marks a reversal of the study's planned implementation and reflects heightened scrutiny of foreign medical research in Africa.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works